Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmaxis Ltd ( (AU:SNT) ) has shared an update.
Syntara Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company is set to quote 281,240 ordinary fully paid securities, with the issue date being June 16, 2025. This move indicates Syntara Limited’s strategic efforts to enhance its market presence and potentially attract more investors. The issuance of these securities could have implications for the company’s financial structure and stakeholder interests.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.25 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Average Trading Volume: 8,462,253
Technical Sentiment Signal: Buy
Current Market Cap: A$108.9M
For an in-depth examination of SNT stock, go to TipRanks’ Overview page.